Labcyte Selects Chayon Laboratories as Exclusive Korean Distributor

Labcyte, the developer of acoustic liquid transfer, with systems in all of the top 10 pharmaceutical companies, today announced the selection of Chayon Laboratories Inc. as its exclusive Korean distributor.

July 21, 2009
Sunnyvale, CA
Sunnyvale, CA — July 21, 2009 —Labcyte, the developer of acoustic liquid transfer, with systems in all of the top 10 pharmaceutical companies, today announced the selection of Chayon Laboratories Inc. as its exclusive Korean distributor.

“Chayon Laboratories will be a great partner for us in Korea,” said Stephen Bates, Sr. Vice President of Sales, Marketing and Service of Labcyte Inc. “As we expand in Asia, Chayon will help us reach users in the growing genomics market. We feel that with the Labcyte platforms, Chayon can meet the genomics customers’ needs for miniaturization, precision and accuracy while remaining contamination-free. Chayon will also reach users in our established markets of pharmaceutical drug discovery, including compound management, high-throughput and secondary screening.

“We are very excited to be chosen by Labcyte as their partner in Korea,” said Mr. S. K. Kim, president of Chayon Laboratories. “We see a great potential market for low-volume transfer devices in Korea. We believe that the growing genomics markets, especially for gene expression, SNP analysis and RNAi, will find that the need for miniaturization is met particularly well by the Labcyte technologies. The superior advantages of the Labcyte products and our understanding of the potential user base in Korea sets up a situation where the customers will have optimal interactions with a local group while reaping the benefits of the best available technology.”

“As more people move to higher-density assays, the touchless liquid handling capabilities offered by the Labcyte acoustic products becomes essential,” said Nick Samaras, Managing Director, Asia-Pacific from his office in Melbourne. “In particular, our Echo® liquid handler provides better results, reduces costs by eliminating consumables and reduces toxic wastes. Our platform technology is also being applied in other fields such as array formation, the microencapsulation of compounds, particle production, proteomics research, the transfer of ultra-viscous materials, cell-based biology and imaging mass spectrometry.”

About Chayon Laboratories Inc.
Chayon Laboratories, Inc., founded in 1997, sells and supports a broad range of technologies to the Korean market for general biochemical and drug discovery research applications, including high throughput screening (HTS) and genomic analyses. Chayon Laboratories takes pride in their service and technical support. For more information, visit www.chayon.co.kr.

About Labcyte Inc.
Labcyte Inc. uses sound to move liquids. This green technology provides significantly better analytical results while saving money. The ‘touchless’ technology provides dramatically better answers by eliminating pipette tips and the adsorption of compounds during transfer, while saving hundreds of thousands of dollars in decreased consumables. Accuracy is maintained from first drop through last for a wide variety of fluids, including many considered intractable by other techniques. The technology is coupled with our Deerac™ instruments to make Labcyte a leader in liquid handling. Together with the Deerac systems, the award-winning Echo liquid handlers are used in all of the top 10 pharmaceutical companies, as well as in leading academic and research institutions worldwide. Labcyte technologies have broad applications including the fields of compound management, genomics, proteomics, particle manufacturing, encapsulation, imaging mass spectrometry, and live-cell transfer. Labcyte is headquartered in Sunnyvale, California with offices in Dublin, Ireland and has 39 U.S., 7 European and two Japanese patents and additional U.S. and international filings. For more information, visit www.labcyte.com.